Transine Therapeutics today announce Andy Billinton as Chief Scientific Officer and triple its facility footprint at The Babraham Research Campus

Learn More

Trading beyond Brexit: The essentials for your SME tenants

Learn More

Furlough Leave – Guidance Updated

Learn More

Business will legally need to disclose climate change risks

Learn More
UKSPA
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.